America Great Health (AAGH) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Alhambra, CA, アメリカ. 現CEOは Mike Qingkun Wang.
AAGH を有する IPO日 2012-09-25, 5 名の正社員, に上場 Other OTC, 時価総額 $2.12M.
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and the manufacturing and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health was founded in 2013 and is headquartered in Alhambra, California.
